» Articles » PMID: 25917866

Enantiomeric Cyclic Peptides with Different Caco-2 Permeability Suggest Carrier-mediated Transport

Overview
Journal Chemistry
Specialty Chemistry
Date 2015 Apr 29
PMID 25917866
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Recently, oral absorption of cyclic hexapeptides was improved by N-methylation of their backbone amides. However, the number and position of N-methylations or of solvent exposed NHs did not correlate to intestinal permeability, measured in a Caco-2 model. In this study, we investigate enantiomeric pairs of three polar and two lipophilic peptides to demonstrate the participation of carrier-mediated transporters. As expected, all the enantiomeric peptides exhibited identical lipophilicity (logD7.4) and passive transcellular permeability determined by the parallel artificial membrane permeability assay (PAMPA). However, the enantiomeric polar peptides exhibited different Caco-2 permeability (Papp) in both directions a-b and b-a. The same trend was observed for one of the lipophilic peptide, whereas the second lipophilic enantiomer pair showed identical Caco-2 permeability (within the errors). These findings provide the first evidence for the involvement of carrier-mediated transport for peptides, especially for those of polar nature.

Citing Articles

Oral Absorption of Middle-to-Large Molecules and Its Improvement, with a Focus on New Modality Drugs.

Asano D, Takakusa H, Nakai D Pharmaceutics. 2024; 16(1).

PMID: 38258058 PMC: 10820198. DOI: 10.3390/pharmaceutics16010047.


Conformations of Macrocyclic Peptides Sampled by Nuclear Magnetic Resonance: Models for Cell-Permeability.

Rudisser S, Matabaro E, Sonderegger L, Guntert P, Kunzler M, Gossert A J Am Chem Soc. 2023; 145(50):27601-27615.

PMID: 38062770 PMC: 10739998. DOI: 10.1021/jacs.3c09367.


Evaluation of PepT1 (SLC15A1) Substrate Characteristics of Therapeutic Cyclic Peptides.

Bajraktari-Sylejmani G, von Linde T, Burhenne J, Haefeli W, Sauter M, Weiss J Pharmaceutics. 2022; 14(8).

PMID: 36015235 PMC: 9415731. DOI: 10.3390/pharmaceutics14081610.


Development of a Therapeutic Peptide for Cachexia Suggests a Platform Approach for Drug-like Peptides.

Gruber K, Ji R, Gallazzi F, Jiang S, Van Doren S, Tao Y ACS Pharmacol Transl Sci. 2022; 5(5):344-361.

PMID: 35592439 PMC: 9112415. DOI: 10.1021/acsptsci.1c00270.


Improvement on Permeability of Cyclic Peptide/Peptidomimetic: Backbone -Methylation as A Useful Tool.

Li Y, Li W, Xu Z Mar Drugs. 2021; 19(6).

PMID: 34072121 PMC: 8229464. DOI: 10.3390/md19060311.